Sana Biotechnology Inc (NASDAQ: SANA) kicked off on Monday, down -6.08% from the previous trading day, before settling in for the closing price of $5.59. Over the past 52 weeks, SANA has traded in a range of $1.26-$7.30.
A company in the Healthcare sector has dropped its sales by -10.60% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 24.25%. With a float of $161.12 million, this company’s outstanding shares have now reached $230.51 million.
Sana Biotechnology Inc (SANA) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Sana Biotechnology Inc is 37.72%, while institutional ownership is 43.51%. The most recent insider transaction that took place on Feb 18 ’25, was worth 237,000. Before that another transaction happened on Jan 16 ’25, when Company’s Officer proposed sale 75,000 for $3.86, making the entire transaction worth $289,500.
Sana Biotechnology Inc (SANA) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.27 earnings per share (EPS), higher than consensus estimate (set at -0.27) by -0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.19 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 24.25% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 14.57% during the next five years compared to -10.60% drop over the previous five years of trading.
Sana Biotechnology Inc (NASDAQ: SANA) Trading Performance Indicators
Take a look at Sana Biotechnology Inc’s (SANA) current performance indicators. Last quarter, stock had a quick ratio of 2.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.06, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.65 in one year’s time.
Technical Analysis of Sana Biotechnology Inc (SANA)
Let’s dig in a bit further. During the last 5-days, its volume was 4.96 million. That was inferior than the volume of 5.76 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 51.60%.
During the past 100 days, Sana Biotechnology Inc’s (SANA) raw stochastic average was set at 69.70%, which indicates a significant increase from 46.94% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.60 in the past 14 days, which was higher than the 0.33 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.84, while its 200-day Moving Average is $3.04. However, in the short run, Sana Biotechnology Inc’s stock first resistance to watch stands at $5.59. Second resistance stands at $5.94. The third major resistance level sits at $6.17. If the price goes on to break the first support level at $5.01, it is likely to go to the next support level at $4.78. The third support level lies at $4.43 if the price breaches the second support level.
Sana Biotechnology Inc (NASDAQ: SANA) Key Stats
The company with the Market Capitalisation of 1.36 billion has total of 237,806K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -266,760 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -93,800 K.
